Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2019 R33 RFA-CA-18-003 TAVANA, HOSSEIN UNIVERSITY OF AKRON A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery Active
2018 R33 RFA-CA-17-011 SCHRUM, ADAM G UNIVERSITY OF MISSOURI-COLUMBIA Multiplex matrix ELISA for T cell protein-interaction networks in cancer Active
2019 R33 RFA-CA-18-003 SCHNECK, JONATHAN P JOHNS HOPKINS UNIVERSITY A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells Active
2018 R33 RFA-CA-17-011 TEWARI, MUNEESH (contact); WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations Active
2020 R21 RFA-CA-19-020 HALL, ADAM ROGER WAKE FOREST UNIVERSITY HEALTH SCIENCES Detecting Diverse Nucleic Acid Biomarkers Of Cancer With Solid-state Nanopores Active
2019 R33 RFA-CA-18-003 SCHIAVINATO EBERLIN, LIVIA UNIVERSITY OF TEXAS, AUSTIN Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation Active
2018 R21 RFA-CA-17-012 GULLEY, MARGARET L UNIV OF NORTH CAROLINA CHAPEL HILL EndoGenus Toolkit: A Biometric Method for Absolute Quantification of Tumor Markers by Massive Parallel Sequencing Active
2020 R21 RFA-CA-19-019 HATTORI, TAKAMITSU NEW YORK UNIVERSITY SCHOOL OF MEDICINE Rational Generation Of High-performance Recombinant Antibodies To Post-translational Modifications Active
2019 R33 RFA-CA-18-003 FIOLKA, RETO PAUL UT SOUTHWESTERN MEDICAL CENTER Multiscale microscope for 3D cancer imaging in model organisms and organoids Active
1999 R43 PAR-98-066 BITTER, GRANT A. BITTECH, INC. DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS Complete
2001 R44 PAR-99-101 RAO, CHANDRA IMMUNICON CORPORATION ANALYSIS OF CIRCULATING CANCER CELLS EARLY IN DISEASE Complete
2004 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. ARTIFICIAL ANTIBODY MIMETICS Complete
2007 R43 RFA-CA-07-008 GORDON, NEAL FRANCIS EPITOME BIOSYSTEMS, INC A STANDARDIZED ANTIBODY MICROARRAY-BASED SYSTEM FOR THE QUANTITATIVE MEASUREMENT Complete
2010 R33 RFA-CA-09-007 KENIS, PAUL J. A. UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN FRET-BASED BIOSENSORS TO MONITOR REDOX IN CELL CYCLE REGULATION Complete
2014 R33 RFA-CA-13-004 TURESKY, ROBERT J. UNIVERSITY OF MINNESOTA CARCINOGEN DNA ADDUCT BIOMARKERS IN FORMALIN FIXED TISSUES Complete
1999 R21 PAR-98-067 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS Complete
2001 R33 PAR-99-100 SIKIC, BRANIMIR I STANFORD UNIVERSITY GENE EXPRESSION PROFILING OF UNKNOWN PRIMARY CANCERS Complete
2003 R43 PAR-01-105 BALGLEY, BRIAN M CALIBRANT BIOSYSTEMS, INC. ITP-BASED SELECTIVE ENRICHMENT OF LOW ABUNDANCE PROTEINS Complete
2007 R21 RFA-CA-07-002 COOPER, LAURENCE J.N. UT MD ANDERSON CANCER CTR UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY Complete
2009 R44 RFA-CA-08-013 ZOU, NIANXIANG BIO-QUICK CORPORATION DEVELOPMENT OF ULTRASOUND-FACILITATED FORMALIN-FIXED AND PARAFFIN-EMBEDDED TISSUE Complete
2013 R33 RFA-CA-12-005 SCHLEGEL, RICHARD GEORGETOWN UNIVERSITY CONDITIONALLY REPROGRAMMED CELLS AS A NOVEL TOOL FOR BIOBANKING Complete
2000 R43 PAR-99-101 MOEN, PHILLIP T ONE CELL SYSTEMS, INC NOVEL METHOD FOR DETECTING NON-HODGKIN'S LYMPHOMA Complete
2002 R43 PAR-01-105 TRNOVSKY, JAN ONE CELL SYSTEMS, INC METHOD FOR DETECTING CHRONIC MYELOGENOUS LEUKEMIA CELLS Complete
2006 R21 RFA-CA-06-004 O'LEARY, TIMOTHY J. AMERICAN REGISTRY OF PATHOLOGY, INC. RECOVERY OF RNA FROM FORMALIN-FIXED TISSUES Complete
2009 R21 RFA-CA-08-006 WIRTZ, DENIS JOHNS HOPKINS UNIVERSITY HIGH-THROUGHPUT INTRACELLULAR MICRORHEOLOGY: A NEW TOOL FOR CANCER RESEARCH Complete
2012 R33 RFA-CA-12-005 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY NANOTRAP TECHNOLOGY FOR ONE STEP PRESERVATION AND AMPLIFICATION OF CANCER BIOMARK Complete
2016 R21 RFA-CA-15-002 MATOUSCHEK, ANDREAS UNIVERSITY OF TEXAS, AUSTIN DEVELOPMENT OF PROTEASOME ADAPTORS TO CATALYTICALLY DEPLETE SPECIFIC PROTEINS FROM CELLS Complete
2000 R21 PAR-99-100 FORTINA, PAOLO M CHILDREN'S HOSPITAL OF PHILADELPHIA FOUR COLOR ARRAY BOUND SNP/MUTATION DETECTION IN CANCER Complete
2002 R33 PAR-01-106 SCHNITZER, JAN EUGENIUSZ SIDNEY KIMMEL CANCER CENTER TECHNOLOGY TO UNMASK ACCESSIBLE TUMOR VASCULAR TARGETS Complete
2005 R33 RFA-CA-05-002 SCHWARTZ, DAVID C. UNIVERSITY OF WISCONSIN MADISON SINGLE MOLECULE GENOME ANALYSIS OF OLIGODENDROGLIOMA Complete
2008 R21 RFA-CA-07-037 YANNELLI, JOHN R. UNIVERSITY OF KENTUCKY CRYOPREPARATION OF PBMC FOR IMMUNOTHERAPY AND IMMUNE ASSESSMENT STUDIES. Complete
2011 R21 RFA-CA-10-005 RAO, JIANGHONG STANFORD UNIVERSITY NANOTECHNOLOGY FOR MULTIPLEX DETECTION OF ENZYMES Complete
2015 R33 RFA-CA-14-004 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS VALIDATION AND ADVANCED DEVELOPMENT OF GLYCAN NODE ANALYSIS IN LUNG CANCER RESEARCH Complete
1999 R43 PAR-98-066 MONFORTE, JOSEPH A GENETRACE SYSTEMS, INC. EXPRESSION MONITORING OF MULTIPLEXED CANCER GENE SETS Complete
2001 R44 PAR-99-101 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM Complete
2004 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER Complete
2007 R43 RFA-CA-07-008 MEDGHALCHI, SUSAN FASGEN, INC. FATTY ACID SYNTHASE PHOSPHORYLATION AS A CANCER BIOMARKER Complete
2010 R33 RFA-CA-09-007 ROBINSON, JOSEPH PAUL PURDUE UNIVERSITY SPECIFIC DETECTION OF CERVICAL CANCERS USING CYTOMETRY-BASED MOLECULAR DIAGNOSTIC Complete
2014 R43 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. B CELL REPERTOIRE MOLECULAR PLATFORM FOR ANTIBODY DRUG DISCOVERY Complete
1999 R21 PAR-98-067 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES ULTRA-SENSITIVE APPROACH FOR MONITORING GENE PRODUCTION Complete
2001 R33 PAR-99-100 TUNG, CHING-HSUAN MASSACHUSETTS GENERAL HOSPITAL IN VIVO IMAGING OF MATRIX METALLOPROTEASE Complete
2003 R44 PAR-01-104 GOLOVLEV, VAL V SCI-TEC, INC. MAGNETICALLY READABLE MICROARRAY Complete
2007 R21 RFA-CA-07-002 KERR, WILLIAM GARROW H. LEE MOFFITT CANCER CTR & RES INST DEFINING THE MULTIPLE MYELOMA KINOME Complete
2009 R44 RFA-CA-07-010 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING Complete
2013 R33 RFA-CA-13-002 KUHN, PETER SCRIPPS RESEARCH INSTITUTE CLINICAL VALIDATION OF THE HD-CTC FLUID BIOPSY IN EARLY DETECTION OF LUNG CANCER. Complete
2017 R21 RFA-CA-16-001 WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Single-molecule counting of cancer biomarker miRNAs in human biofluids Complete
2000 R43 PAR-99-101 SERBEDZIJA, GEORGE N PHYLONIX PHARMACEUTICALS, INC. WHOLE ANIMAL APOPTOSIS ASSAY FOR CANCER DRUG SCREENING Complete
2002 R43 PAR-01-105 LATHAM, GARY J AMBION, INC. ENZYMATIC TOOLS FOR DEGRADING TISSUE AND PRESERVING RNA Complete
2006 R21 RFA-CA-06-004 JU, JINGFANG UNIVERSITY OF SOUTH ALABAMA NOVEL METHOD FOR ISOLATING ACTIVELY TRANSLATED MRNAS Complete
2009 R21 RFA-CA-08-006 KANDEL, EUGENE S ROSWELL PARK CANCER INSTITUTE CORP ARRAY-ASSISTED INSERTIONAL MUTAGENESIS FOR MOLECULAR ANALYSIS OF CANCER Complete

Pages